Explore how the FDA distinguishes between standard (10-month) and priority (8-month) review timelines for generic drug applications. Learn about GDUFA III rules, the new U.S. manufacturing pilot program, and strategies to avoid delays.
Understanding FDA Generic Approval: An Easy Overview for Patients
22 January, 2026
Learn how the FDA ensures generic drugs are just as safe and effective as brand-name medications. Discover the approval process, why generics cost less, and when to ask your doctor about switching.